Raltegravir (Isentress)

Published November 13, 2007; Updated January 08, 2014
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-01
Selected Reference
6. Lennox J, Dejesus E, Lazzarin A, et al. STARTMRK, A Phase III study of the safety and efficacy of raltegravir (RAL)-based vs efavirenz (EFV)-based combination therapy in treatment-naive HIV-infected patients. In: Program and abstracts of the 48th International Conference on Antimicrobial Agents and Chemotherapy; October 25-28, 2008; Washington, D.C. Abstract H-896a.